The role of analgesic blocking in the management of cancer pain: current trends. a review article.
The significant role of reversible and neurolytic analgesic blocking in the management of cancer pain in general is presented. It is pointed out that this modality of therapy may play a very significant role in the management of many such patients. It is pointed out that blocks of the peripheral as well as the central nervous system should be considered early rather than late in these disease syndromes in order to prevent central fixation. It is obvious that these procedures should be employed much more extensively than is generally the case at the present time. The opinions expressed are based upon over 30 years of clinical experience and a review of the current literature dealing with the management of pain.
D000008:Abdominal Neoplasms / Q000150:complications; D000700:Analgesics / Q000009:adverse effects; D001943:Breast Neoplasms / Q000150:complications; D002908:Chronic Disease; D006258:Head and Neck Neoplasms / Q000150:complications; D006801:Humans; D008175:Lung Neoplasms / Q000150:complications; D009369:Neoplasms / Q000150:complications / Q000188:drug therapy*; D009407:Nerve Block; D010146:Pain / Q000188:drug therapy* / Q000209:etiology / Q000601:surgery; D011379:Prognosis
D000700:Analgesics